E 111 Pill: blue, round, 8mm
The pill with imprint E 111 (Blue, Round, 8mm) has been identified as Amphetamine and Dextroamphetamine 10 mg and is used for ADHD, and Narcolepsy. It belongs to the drug class CNS stimulants and is classified as CSA Schedule 2 (High potential for abuse).
Images for E 111
Amphetamine and Dextroamphetamine
- Imprint
- E 111
- Strength
- 10 mg
- Color
- Blue
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- Inactive Ingredients
-
FD&C Blue No. 1,
lactose monohydrate,
magnesium stearate,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00185-0111 (Discontinued) | Eon Labs Inc. |
| 00185-0842 | Eon Labs Inc. |
| 68084-0936 (Discontinued) | Amerisource Health Services |
Related images for "E 111"
More about amphetamine / dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,183)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- En español
Patient resources
- Amphetamine and dextroamphetamine drug information
- Dextroamphetamine and amphetamine (Advanced Reading)
- Dextroamphetamine and Amphetamine Tablets
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
Other brands
Adderall, Adderall XR, Mydayis
Professional resources
- Amphetamine monograph
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate (FDA)
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate ER Capsules (FDA)
Other brands
Adderall, Adderall XR, Mydayis
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.